American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009'
19 August 2009 - 1:59AM
PR Newswire (US)
NEW YORK, Aug. 18 /PRNewswire-Asia-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE:AOB), ("the Company" or "AOBO"), a
pharmaceutical company dedicated to improving health through the
development, manufacture and commercialization of a broad range of
prescription and over the counter ("OTC") products in China, today
announced that two of AOBO's branded products, Jinji Capsules and
Boke Nasal Spray, were awarded the designation of "China's Top
Branded Drugs of 2009" at an award ceremony held in Shanghai on
August 11, 2009. The selection process took one year to complete
and, in total, 60 branded drugs manufactured by 52 Chinese and
global pharmaceutical companies were included in the list. The
assessment committee was composed of experts in the areas of
clinical work, pharmaceuticals, marketing and branding, and the
selection criteria included the drugs' quality, efficacy,
health-economic indicators, market share and brand influence. Mr.
Tony Liu, Chairman and Chief Executive Officer of American Oriental
Bioengineering, commented, "We are very honored to receive this
recognition from industry experts. This important distinction
validates our branding strategy and adds credibility to these
brands on a national basis. This award speaks to the strength of
our brand value in the competitive Chinese market, and builds on
our achievement of being named a Top 20 Most Competitive Public
Pharmaceutical Company in China, which we received in July." Jinji
Capsule (Prescription and OTC Product) The Jinji brand
gynecological products are AOBO's flagship women's health products.
Leading Jinji products include Jinji Capsule and Jinji Yi Mu Cau.
Jinji Capsule treats various women's health issues such as
gynecological inflammation, endometritis and annexitis and is
complementary to AOBO's other product lines in the women's health
marketplace. Based on government data, there are 147 million women
in China that suffer from gynecological inflammation. Boke Nasal
Spray (OTC Product) Boke nasal spray is an over-the-counter
pharmaceutical product approved and marketed for the treatment of
sinus congestion from common cold, stuffy nose, chronic rhinitis,
allergic rhinitis and nasosinusitis. The spray is marketed under
the product name of Ditong Biyanshui Penwuji ("Ditong"). Ditong is
approved by the SFDA in China and marketed as a branded drug. This
product consists of a combination of many parts of TCM plants,
including roots, vines, flowers and stems. Treatment dosage is
three to four times a day and two sprays into each nostril. About
American Oriental Bioengineering, Inc. American Oriental
Bioengineering, Inc. is a pharmaceutical company dedicated to
improving health through the development, manufacture and
commercialization of a broad range of prescription and over the
counter products in China. Statements made in this press release
are forward-looking and are made pursuant to the safe harbor
provisions of the Securities Litigation Reform Act of 1995. Such
statements involve risks and uncertainties that may cause actual
results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological
and other factors identified in the Company's filings with the
Securities and Exchange Commission, including the Form 10-K for the
year ended December 31, 2008, may cause actual results or events to
differ materially from those described in the forward looking
statements in this press release. The Company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise. For more information, please contact: Integrated
Corporate Relations, Inc. Ashley M. Ammon Tel: +1-203-682-8208
DATASOURCE: American Oriental Bioengineering, Inc. CONTACT:
Integrated Corporate Relations, Inc., Ashley M. Ammon, +1-203-
682-8208 for American Oriental Bioengineering, Inc.
Copyright
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jul 2023 to Jul 2024